[ Mon, Jan 28th 2013 ]: WOPRAI
Brian Johnson Upgraded (ST) to Buy and Increased Target to $43 on, Jan 28th, 2013
[ Mon, Jan 28th 2013 ]: WOPRAI
Matthew Niknam Downgraded (CCI) to Strong Sell on, Jan 28th, 2013
[ Mon, Jan 28th 2013 ]: WOPRAI
[ Mon, Jan 28th 2013 ]: WOPRAI
Atif Malik Maintained (TER) at Strong Buy with Increased Target to $19 on, Jan 28th, 2013
[ Mon, Jan 28th 2013 ]: WOPRAI
Ross Gilardi Upgraded (TEX) to Hold and Increased Target to $34 on, Jan 28th, 2013
[ Mon, Jan 28th 2013 ]: WOPRAI
Brian Meredith Maintained (AGO) at Strong Buy with Increased Target to $21 on, Jan 28th, 2013
[ Mon, Jan 28th 2013 ]: WOPRAI
John Glass Maintained (YUM) at Buy with Decreased Target to $72 on, Jan 28th, 2013
[ Mon, Jan 28th 2013 ]: WOPRAI
Tim Casey Maintained (TU) at Buy and Held Target at $18 on, Jan 28th, 2013
[ Mon, Jan 28th 2013 ]: WOPRAI
Edward Tenthoff Maintained (ALNY) at Buy with Increased Target to $35 on, Jan 28th, 2013
[ Mon, Jan 28th 2013 ]: WOPRAI
Amit Harchandani Upgraded (ASML) to Strong Buy and Held Target at $85 on, Jan 28th, 2013
[ Mon, Jan 28th 2013 ]: WOPRAI
Richard Safran Downgraded (ATI) to Hold and Decreased Target to $29 on, Jan 28th, 2013
[ Mon, Jan 28th 2013 ]: WOPRAI
Robbie Marcus Maintained (BSX) at Hold with Increased Target to $7 on, Jan 28th, 2013
[ Mon, Jan 28th 2013 ]: WOPRAI
Gerrick Johnson Maintained (BC) at Buy with Increased Target to $42 on, Jan 28th, 2013
[ Fri, Jan 25th 2013 ]: WOPRAI
Adrienne Colby Maintained (AVT) at Strong Buy with Increased Target to $40 on, Jan 25th, 2013
[ Fri, Jan 25th 2013 ]: WOPRAI
Bhupender Bohra Maintained (AME) at Strong Buy with Increased Target to $50 on, Jan 25th, 2013
[ Fri, Jan 25th 2013 ]: WOPRAI
David Toung Upgraded (AMGN) to Strong Buy on, Jan 25th, 2013
[ Fri, Jan 25th 2013 ]: WOPRAI
Kevin Cassidy Maintained (SYNA) at Strong Buy with Increased Target to $38 on, Jan 25th, 2013
[ Fri, Jan 25th 2013 ]: WOPRAI
[ Fri, Jan 25th 2013 ]: WOPRAI
Kash Rangan Upgraded (ADSK) to Strong Buy and Increased Target to $45 on, Jan 25th, 2013
[ Fri, Jan 25th 2013 ]: WOPRAI
Michael Linenberg Maintained (ALK) at Hold with Increased Target to $24 on, Jan 25th, 2013
[ Fri, Jan 25th 2013 ]: WOPRAI
Michael Baudendistel Downgraded (TRN) to Hold on, Jan 25th, 2013
[ Fri, Jan 25th 2013 ]: WOPRAI
Timothy Arcuri Maintained (TER) at Hold with Increased Target to $17 on, Jan 25th, 2013
[ Fri, Jan 25th 2013 ]: WOPRAI
Christian Schwab Downgraded (TER) to Hold and Held Target at $17 on, Jan 25th, 2013
[ Fri, Jan 25th 2013 ]: WOPRAI
Michael Graham Maintained (AMZN) at Hold with Increased Target to $15 on, Jan 25th, 2013
[ Fri, Jan 25th 2013 ]: WOPRAI
Tore Svanberg Maintained (CRUS) at Strong Buy with Decreased Target to $42 on, Jan 25th, 2013
[ Fri, Jan 25th 2013 ]: WOPRAI
George Staphos Maintained (WY) at Strong Buy with Increased Target to $35 on, Jan 25th, 2013
Uroplasty Inc (NASDAQ:UPI), Down By 8.51% ($0.24) From $2.820 After BUYINS.NET Report Predicted Weakness After Earnings
January 25, 2013 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Wednesday, January 23rd 2013 stating that Uroplasty Inc (NASDAQ:UPI) was expected to be Down After its earnings release. Click here to view the BUYINS.NET report:
http://www.buyins.net/releases/?sym=upi&id=342474
At the time this story was written, Uroplasty Inc (NASDAQ:UPI) is Down By 8.51% ($0.24) From $2.820 since the BUYINS.NET report was released.
The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at
http://www.squeezetrigger.com/services/strat/mh.php
Uroplasty Inc (NASDAQ:UPI) - Uroplasty, Inc., a medical device company, engages in the development, manufacture, and marketing of products for the treatment of voiding dysfunctions. The company principally offers Urgent PC Neuromodulation system, a minimally-invasive and office-based therapy for the treatment of overactive bladder and the associated symptoms of urinary urgency, urinary frequency, and urge incontinence; and Macroplastique, a urethral bulking agent for the treatment of adult female stress urinary incontinence due to intrinsic sphincter deficiency, as well as for the treatment of male stress incontinence, fecal incontinence, and vesicoureteral reflux. It also provides PTQ Implants, which offers a minimally-invasive, soft-textured permanent implant for treatment of fecal incontinence; VOX Implants, a tissue bulking material for otolaryngology vocal cord rehabilitation applications; and is involved in the distribution of wound care products. The company sells its products primarily to urologists, urogynecologists, and gynecologists through a direct sales organization in the United States, the United Kingdom, and the Netherlands, as well as through distributors in other markets. Uroplasty, Inc. was incorporated in 1992 and is headquartered in Minnetonka, Minnesota..
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.
INVESTMENTS & TRADING
SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.
GATS -- tracks and quantifies known trading strategies.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Uroplasty Inc (NASDAQ:UPI) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net